Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance

Catherine A Cremona1, Rocio Sancho1, Markus E Diefenbacher1

  • 1The Francis Crick Institute, Lincoln's Inn Fields Laboratory, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.

Seminars in Cancer Biology
|September 28, 2015
PubMed

Insights

F-box and WD repeat domain-containing 7 (Fbw7) protein acts as a tumor suppressor by degrading oncoproteins. However, its dysregulation can promote cancer, highlighting its complex role in tumorigenesis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Fbw7 is a key regulator of stem cell function and a known tumor suppressor.
  • It controls cell proliferation, differentiation, and apoptosis by targeting transcription factors for degradation.
  • Accumulating evidence from various studies reinforces its roles in cancer.

Purpose of the Study:

  • To summarize recent findings on Fbw7's tumor-suppressive functions across multiple tissues.
  • To explore the rare oncogenic roles of Fbw7.
  • To discuss regulatory mechanisms of Fbw7-mediated ubiquitination, including counteracting proteases.

Main Methods:

  • Review of in vitro studies
  • Analysis of mouse models
  • Examination of human patient data

Main Results:

  • Fbw7 exhibits tumor-suppressive activity in various tissues.
  • Specific conditions reveal Fbw7 can possess oncogenic properties.
  • USP28 and other deubiquitinating enzymes can stabilize oncoproteins by counteracting Fbw7.

Conclusions:

  • Deubiquitination of Fbw7 substrates is a critical pro-tumorigenic mechanism.
  • The interplay between Fbw7 and deubiquitinating enzymes is crucial in cancer.
  • Targeting the ubiquitin-proteasome system, including Fbw7 pathways, offers potential for novel cancer therapies.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
Cell-matrix's Response to Mechanical Forces01:13

Cell-matrix's Response to Mechanical Forces

In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue. 
Anchoring junctions mechanically attach a cell to the...
3.8K